USV has a portfolio of 83 patent submissions for APIs, Finished Dosages and Biosimilars. Of these 30 patents have been granted and 53 submissions are pending approval.
|
Finished Products
|
| |
Granted |
10 |
| |
Pending |
12 |
| |
Total |
22 |
APIs |
| |
Granted |
17 |
| |
Pending |
31 |
| |
Total |
48 |
Biologics |
| |
Granted |
03 |
| |
Pending |
10 |
| |
Total |
13 |
|
